Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report-Reference-Cited by-同舟云学术

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report

Published:2018-01-24 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Narumi Yoshitsugu,Yoshida Ryohei,Minami Yoshinori,Yamamoto Yasushi,Takeguchi Shiori,Kano Kohei,Takahashi Kae,Saito Tsukasa,Sawada Jun,Terui Hiroya,Katayama Takayuki,Sasaki Takaaki,Ohsaki Yoshinobu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-3997-2.pdf

Reference14 articles.

1. Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373(2):123–35.

2. Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373(17):1627–39.

3. Champiat S, Lambotte O, Barreau E, Belkhir R, Berdelou A, Carbonnel F, Cauquil C, Chanson P, Collins M, Durrbach A, et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol. 2016;27(4):559–74.

4. Williams TJ, Benavides DR, Patrice KA, Dalmau JO, de Avila AL, Le DT LEJ, Probasco JC, Mowry EM. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol. 2016;73(8):928–33.

5. Tanaka R, Maruyama H, Tomidokoro Y, Yanagiha K, Hirabayashi T, Ishii A, Okune M, Inoue S, Sekine I, Tamaoka A, et al. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barre syndrome: a case report. Jpn J Clin Oncol. 2016;46(9):875–8.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders;Journal of Neurology;2024-05-21

2. Update on Neuro-ophthalmic Manifestations of Immune Checkpoint Inhibitors;Current Neurology and Neuroscience Reports;2024-03-18

3. Neurologic manifestations of autoimmunity with immune checkpoint inhibitors;Handbook of Clinical Neurology;2024

4. Neuropsychological issues related to immunotherapy;Neuropsychological and Psychosocial Foundations of Neuro-Oncology;2024

5. Neuromyelitis optica associated with the use of Atezolizumab in a patient with advanced lung adenocarcinoma;Neurological Sciences;2023-12-13